Creative Biolabs is proud to announce an upcoming industry webinar on engineered human 3D brain tissues for neurodegenerative disease modeling.

Patient-derived organoids contribute to precision medicine by enabling direct drug testing on a patient’s tumor. These models ...

Researchers from UTS and Monash University have identified vitronectin as a key protein driving abnormal lung scarring in ...

For more than 25 years, lab-on-a-chip technology has allowed researchers to model human organs and blood vessels using real ...

For decades, the pharmaceutical industry has discussed moving away from in vivo models in preclinical research. Now, it’s more than a conversation. The FDA’s roadmap for reducing animal testing, ...

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety, today announced revenue ...

Researchers have uncovered a surprising culprit behind sleep loss in Alzheimer’s disease: the brain’s own immune cells. In ...

A stepwise HIV vaccine strategy has induced broadly neutralizing antibodies in primates, hinting that a truly protective HIV ...

Auxilium says it bioprinted kidney and liver tissue on the ISS, a first. The near-term payoff is drug-testing organoids, not transplant organs.

Pulmonary fibrosis is a deadly disease in which scar tissue grows in the lungs, making breathing more difficult.

The pharmaceutical industry loses billions each year on drug candidates that perform well in animal testing but ultimately fail in human trials, most often because of safety concerns. As regulators ...

Unlike accidental cell death, some cells can actively decide to die through a controlled process. This is called programmed cell death and can occur in different forms, including apoptosis and ...